Biovail, Juvantia, Santhera Pharmaceutical Holdings AG deal

Santhera completed its previously announced acquisition of Juvantia in a stock deal valued at CHF3.3 million ($3.2 million) based on Santhera's close of CHF30.80 on Oct. 2, the last trading day before the deal closed. ...